Last reviewed · How we verify
Lidocaine Hydrochloride with Epinephrine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Lidocaine Hydrochloride with Epinephrine (Lidocaine Hydrochloride with Epinephrine) — NYU Langone Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride with Epinephrine TARGET | Lidocaine Hydrochloride with Epinephrine | NYU Langone Health | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lidocaine Hydrochloride with Epinephrine CI watch — RSS
- Lidocaine Hydrochloride with Epinephrine CI watch — Atom
- Lidocaine Hydrochloride with Epinephrine CI watch — JSON
- Lidocaine Hydrochloride with Epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). Lidocaine Hydrochloride with Epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/lidocaine-hydrochloride-with-epinephrine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab